Cargando…
Fibroblast growth factor 23, iron and inflammation – are they related in early stages of chronic kidney disease?
INTRODUCTION: Fibroblast growth factor 23 (FGF-23) levels are elevated in impaired renal function. Inflammation and iron are potential regulators of FGF-23. The aim of the study was to evaluate the association between FGF-23 concentration, novel iron status biomarkers and inflammatory parameters amo...
Autores principales: | Lukaszyk, Ewelina, Lukaszyk, Mateusz, Koc-Zorawska, Ewa, Bodzenta-Lukaszyk, Anna, Malyszko, Jolanta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510515/ https://www.ncbi.nlm.nih.gov/pubmed/28721153 http://dx.doi.org/10.5114/aoms.2016.58647 |
Ejemplares similares
-
Zonulin, inflammation and iron status in patients with early stages of chronic kidney disease
por: Lukaszyk, Ewelina, et al.
Publicado: (2017) -
GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients
por: Lukaszyk, Ewelina, et al.
Publicado: (2016) -
Biomarkers of delayed graft function as a form of acute kidney injury in kidney transplantation
por: Malyszko, Jolanta, et al.
Publicado: (2015) -
Omalizumab treatment in brittle asthma
por: Skiepko, Roman, et al.
Publicado: (2014) -
Changes in blood eosinophilia during omalizumab therapy as a predictor of asthma exacerbation
por: Skiepko, Roman, et al.
Publicado: (2014)